BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4087272)

  • 1. Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.
    Edelson JD; Hyland RH; Ramsden M; Chamberlain DW; Kortan P; Meindok HO; Klein MH; Braude AC; Lee P; Rebuck AS
    J Rheumatol; 1985 Oct; 12(5):957-63. PubMed ID: 4087272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
    Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
    J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
    Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
    Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary inflammation in systemic sclerosis. An assessment by bronchoalveolar lavage].
    Salaffi F; Subiaco S; Carotti M; Blasetti P; Cervini C
    Recenti Prog Med; 1994 Oct; 85(10):475-80. PubMed ID: 7809460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
    Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
    Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of bronchoalveolar lavage in progressive systemic scleroderma (author's transl)].
    König G; Luderschmidt C; Clocuh YP; Scherer U; Fruhmann G
    Dtsch Med Wochenschr; 1982 May; 107(19):723-7. PubMed ID: 7075490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage.
    Line BR; Fulmer JD; Reynolds HY; Roberts WC; Jones AE; Harris EK; Crystal RG
    Am Rev Respir Dis; 1978 Aug; 118(2):355-65. PubMed ID: 697186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of homogeneity of alveolitis in pulmonary sarcoidosis by bilateral bronchoalveolar lavage, gallium-67 lung uptake, and chest radiograph.
    Staton GW; Check IJ; Fajman WA; Gilman MJ; Pine JR
    Sarcoidosis; 1987 Mar; 4(1):8-12. PubMed ID: 3589196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
    Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
    Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Gallium Arsenide (CAS No. 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Sep; 492():1-306. PubMed ID: 12563348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchioalveolar angiotensin converting enzyme activity. Value in assessing disease activity in sarcoidosis.
    Cummiskey J; LaSure R; Yee J
    J Med; 1984; 15(3):213-25. PubMed ID: 6098625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
    Vatrella A; Bocchino M; Perna F; Scarpa R; Galati D; Spina S; Pelaia G; Cazzola M; Sanduzzi A
    Respir Med; 2007 Jul; 101(7):1383-9. PubMed ID: 17369033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.